NIKKEI 225
27,679.84 -546.24 (-1.94%) HANG SENG
18,654.94 -81.50 (-0.43%) CRUDE OIL
81.51 +0.29 (+0.36%) GOLD FUTURES
1,812.00 -3.20 (-0.18%) DOW
34,395.01 -194.76 (-0.56%) BTC-GBP
13,832.45 -239.27 (-1.70%)
Zealand Pharma A/S (0NZU.L)
| Previous close | 118.72 |
| Open | 123.20 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 123.20 - 124.50 |
| 52-week range | 123.20 - 124.50 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Globe Newswire
Total number of shares and voting rights in Zealand Pharma at November 30, 2022
Company announcement – No. 54 / 2022 Total number of shares and voting rights in Zealand Pharma at November 30, 2022 Copenhagen, Denmark and Boston, MA, U.S. November 30, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Compa
- Globe Newswire
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Company announcement – No. 53 / 2022 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark and Boston, MA, U.S. November 17, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 123,993 divided into 123,993 new shares with a nominal value
- Globe Newswire
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 52 / 2022 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark and Boston, MA, U.S. November 17, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's sha
